Parietal and chief cell sensitivity to pentagastrin stimulation before and after cimetidine treatment for duodenal ulcer
- PMID: 370968
- DOI: 10.3109/00365527909179855
Parietal and chief cell sensitivity to pentagastrin stimulation before and after cimetidine treatment for duodenal ulcer
Abstract
Gastric acid and pepsin output in response to 0.10 and 6.0 microgram . kg-1h-1 of pentagastrin was studied in ten duodenal ulcer patients before and after cessation of 6 weeks of cimetidine treatment, 1 g/day. Acid output in response to the low dose of pentagastrin was on average 63% of the response to the high dose before and on average 65% after treatment. The corresponding values for pepsin output were on average 88% both before and after treatment. Thus, the parietal and chief cell sensitivity stayed unchanged after cimetidine treatment. Mean maximal acid output decreased insignificantly, from 39.4 mmol/h before 34.9 mmol/h after cimetidine treatment. The results suggest an unchanged gastric acid and pepsin secretion capacity after short-term treatment with cimetidine for duodenal ulcer.
Similar articles
-
Effect of cimetidine on pentagastrin-stimulated gastric acid and pepsin secretion before and after 6 weeks of cimetidine treatment.Scand J Gastroenterol. 1978;13(2):193-7. doi: 10.3109/00365527809181747. Scand J Gastroenterol. 1978. PMID: 345415
-
Effect of cimetidine on pentagastrin-stimulated gastric secretion before and after proximal gastric vagotomy for duodenal ulcer.Scand J Gastroenterol. 1978;13(6):679-84. doi: 10.3109/00365527809181781. Scand J Gastroenterol. 1978. PMID: 358367
-
Effect of cimetidine treatment on parietal and chief cell sensitivity to histamine and on catabolism of histamine in duodenal ulcer patients.Scand J Gastroenterol. 1980;15(6):749-54. doi: 10.3109/00365528009181525. Scand J Gastroenterol. 1980. PMID: 6782649
-
Parietal and chief cell sensitivity to histamine and pentagastrin stimulation before and after cimetidine treatment in healthy subjects.Scand J Gastroenterol. 1979;14(8):933-8. Scand J Gastroenterol. 1979. PMID: 119307
-
The developmental physiology of the stomach: possible contributions to the regulatory disturbances of duodenal ulcer disease.Proc Soc Exp Biol Med. 1984 Feb;175(2):119-26. doi: 10.3181/00379727-175-41777. Proc Soc Exp Biol Med. 1984. PMID: 6141567 Review.
Cited by
-
Alteration of H2 receptor sensitivity in duodenal ulcer patients.Gut. 1989 May;30(5):701-3. doi: 10.1136/gut.30.5.701. Gut. 1989. PMID: 2731766 Free PMC article. No abstract available.
-
Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study.Dig Dis Sci. 1980 Feb;25(2):88-91. doi: 10.1007/BF01308302. Dig Dis Sci. 1980. PMID: 6986242 Clinical Trial.
-
Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcer.Dig Dis Sci. 1991 Dec;36(12):1685-90. doi: 10.1007/BF01296610. Dig Dis Sci. 1991. PMID: 1748035
-
The H2-receptor antagonist era in duodenal ulcer disease.Yale J Biol Med. 1992 Nov-Dec;65(6):639-48;discussion 689-92. Yale J Biol Med. 1992. PMID: 1364125 Free PMC article. Review.
-
Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.Gut. 1992 Feb;33(2):175-8. doi: 10.1136/gut.33.2.175. Gut. 1992. PMID: 1541412 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources